Literature DB >> 20549390

Viable fertile mice generated from fully pluripotent iPS cells derived from adult somatic cells.

Xiao-yang Zhao1, Wei Li, Zhuo Lv, Lei Liu, Man Tong, Tang Hai, Jie Hao, Xiang Wang, Liu Wang, Fanyi Zeng, Qi Zhou.   

Abstract

Previous studies demonstrated that induced pluripotent stem (iPS) cells could produce viable mice through tetraploid complementation, which was thought to be the most stringent test for pluripotency. However, these highly pluripotent iPS cells were previously reported to be generated from fibroblasts of embryonic origin. Achieving fully pluripotent iPS cells from multiple cell types, especially easily accessible adult tissues, will lead to a much greater clinical impact. We successfully generated high-pluripotency iPS cells from adult tail tip fibroblasts (TTF) that resulted in viable, full-term, fertile TTF-iPS animals with no obvious teratoma formation or other developmental abnormalities. Comparison of iPS cells from embryonic origin (MEF), progenitor cells (neural stem cells) or differentiated somatic cells (TTF) reveals that fully pluripotent developmental potential can be reached by each cell type, although with different induction efficiencies. This work provides the means for studying the mechanisms and regulation of direct reprogramming, and has encouraging implications for future clinical applications and therapeutic interventions.

Entities:  

Mesh:

Year:  2010        PMID: 20549390     DOI: 10.1007/s12015-010-9160-3

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  16 in total

1.  Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture.

Authors:  Qi-Long Ying; Marios Stavridis; Dean Griffiths; Meng Li; Austin Smith
Journal:  Nat Biotechnol       Date:  2003-01-13       Impact factor: 54.908

2.  RNA transcript profiling during zygotic gene activation in the preimplantation mouse embryo.

Authors:  Fanyi Zeng; Richard M Schultz
Journal:  Dev Biol       Date:  2005-07-01       Impact factor: 3.582

3.  Inefficient reprogramming of the hematopoietic stem cell genome following nuclear transfer.

Authors:  Kimiko Inoue; Narumi Ogonuki; Hiromi Miki; Michiko Hirose; Shinichi Noda; Jin-Moon Kim; Fugaku Aoki; Hiroyuki Miyoshi; Atsuo Ogura
Journal:  J Cell Sci       Date:  2006-04-18       Impact factor: 5.285

Review 4.  Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

Authors:  Rudolf Jaenisch; Richard Young
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

5.  Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Authors:  Jacob Hanna; Marius Wernig; Styliani Markoulaki; Chiao-Wang Sun; Alexander Meissner; John P Cassady; Caroline Beard; Tobias Brambrink; Li-Chen Wu; Tim M Townes; Rudolf Jaenisch
Journal:  Science       Date:  2007-12-06       Impact factor: 47.728

6.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

7.  iPS cells produce viable mice through tetraploid complementation.

Authors:  Xiao-yang Zhao; Wei Li; Zhuo Lv; Lei Liu; Man Tong; Tang Hai; Jie Hao; Chang-long Guo; Qing-wen Ma; Liu Wang; Fanyi Zeng; Qi Zhou
Journal:  Nature       Date:  2009-09-03       Impact factor: 49.962

8.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

9.  Embryonic stem cells alone are able to support fetal development in the mouse.

Authors:  A Nagy; E Gócza; E M Diaz; V R Prideaux; E Iványi; M Markkula; J Rossant
Journal:  Development       Date:  1990-11       Impact factor: 6.868

10.  Reprogramming of pancreatic beta cells into induced pluripotent stem cells.

Authors:  Matthias Stadtfeld; Kristen Brennand; Konrad Hochedlinger
Journal:  Curr Biol       Date:  2008-05-22       Impact factor: 10.834

View more
  19 in total

Review 1.  Chromatin structure of pluripotent stem cells and induced pluripotent stem cells.

Authors:  Paul Delgado-Olguín; Félix Recillas-Targa
Journal:  Brief Funct Genomics       Date:  2011-01       Impact factor: 4.241

2.  Genomic instability in induced stem cells.

Authors:  C E Pasi; A Dereli-Öz; S Negrini; M Friedli; G Fragola; A Lombardo; G Van Houwe; L Naldini; S Casola; G Testa; D Trono; P G Pelicci; T D Halazonetis
Journal:  Cell Death Differ       Date:  2011-02-11       Impact factor: 15.828

Review 3.  Recent advances in the development of new transgenic animal technology.

Authors:  Xiangyang Miao
Journal:  Cell Mol Life Sci       Date:  2012-07-26       Impact factor: 9.261

Review 4.  Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery.

Authors:  Erkan Kiris; Krishna P Kota; James C Burnett; Veronica Soloveva; Christopher D Kane; Sina Bavari
Journal:  Expert Rev Mol Diagn       Date:  2014-01-23       Impact factor: 5.225

5.  Androgenetic haploid embryonic stem cells produce live transgenic mice.

Authors:  Wei Li; Ling Shuai; Haifeng Wan; Mingzhu Dong; Meng Wang; Lisi Sang; Chunjing Feng; Guan-Zheng Luo; Tianda Li; Xin Li; Libin Wang; Qin-Yuan Zheng; Chao Sheng; Hua-Jun Wu; Zhonghua Liu; Lei Liu; Liu Wang; Xiu-Jie Wang; Xiao-Yang Zhao; Qi Zhou
Journal:  Nature       Date:  2012-09-30       Impact factor: 49.962

Review 6.  Adult somatic cells to the rescue: nuclear reprogramming and the dispensability of gonadal germ cells.

Authors:  Charles A Easley; David R Latov; Calvin R Simerly; Gerald Schatten
Journal:  Fertil Steril       Date:  2014-01       Impact factor: 7.329

7.  Tetraploid complementation proves pluripotency of induced pluripotent stem cells derived from adipose tissue.

Authors:  C Zhou; X Cai; Y Fu; X Wei; N Fu; J Xie; Y Lin
Journal:  Cell Prolif       Date:  2014-11-28       Impact factor: 6.831

Review 8.  Gamete derivation from embryonic stem cells, induced pluripotent stem cells or somatic cell nuclear transfer-derived embryonic stem cells: state of the art.

Authors:  Charles A Easley; Calvin R Simerly; Gerald Schatten
Journal:  Reprod Fertil Dev       Date:  2014-12       Impact factor: 2.311

9.  Therapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia.

Authors:  Guanheng Yang; Wansheng Shi; Xingyin Hu; Jingzhi Zhang; Zhijuan Gong; Xinbing Guo; Zhaorui Ren; Fanyi Zeng
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

Review 10.  Stem cell therapeutic possibilities: future therapeutic options for male-factor and female-factor infertility?

Authors:  Charles A Easley; Calvin R Simerly; Gerald Schatten
Journal:  Reprod Biomed Online       Date:  2013-03-26       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.